Skip to main content

Immuneering Corp 8-K, filed Nov 9, 2026

Immuneering Corp (IMRX)

8-K 2026-11-09 For: 2026-11-09
View Original
Added on November 09, 2026

About this 8-K

Immuneering Corp filed this 8-K on November 9, 2026.

Immuneering Corporation appointed Grant C. Bogle, MBA, as a Class III Director on November 9, 2026. He will receive compensation under the company’s arrangements for non-employee directors and has not joined a board committee. AI summary

Items reported

  • Item 5.02: Director or officer change, or executive pay